HYPERURICEMIA
Clinical trials for HYPERURICEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERURICEMIA trials appear
Sign up with your email to follow new studies for HYPERURICEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gout drug dotinurad shows promise in early trial
Disease control CompletedThis completed study tested a new drug called dotinurad in 20 U.S. adults with gout and high uric acid. Researchers looked at how the drug works in the body, both alone and when taken with the standard gout medicine allopurinol. The goal was to understand dosing and potential dru…
Matched conditions: HYPERURICEMIA
Phase: PHASE1, PHASE2 • Sponsor: Urica Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New gout pill shows promise in large trial
Disease control CompletedThis Phase 3 study tested AR882, a drug designed to lower uric acid levels in people with gout. Over 800 participants took either a 50 mg or 75 mg dose of AR882 or a placebo daily for 12 months. The main goal was to see if AR882 could bring uric acid below 6 mg/dL at 6 months, wh…
Matched conditions: HYPERURICEMIA
Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New gout drug shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called LC350189 in 156 adults with gout and high uric acid. The goal was to see if different doses could safely lower uric acid below target levels over 12 weeks. Participants took the drug or a placebo, and researchers measured uric acid in the b…
Matched conditions: HYPERURICEMIA
Phase: PHASE2 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Digital health trial tests home monitoring for seniors in taiwan
Disease control CompletedThis completed trial in Taiwan tested whether a digital health program helps middle-aged and older adults manage conditions like high blood pressure, diabetes, and high cholesterol. 199 participants from four communities used smart devices to measure their health data at home, wh…
Matched conditions: HYPERURICEMIA
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New gout pill shows promise in lowering uric acid levels
Disease control CompletedThis study tested a new medicine called tigulixostat in 354 adults with gout and high uric acid. Participants took one of three doses or a placebo for 6 months. The main goal was to see if the drug could keep uric acid below a target level. The trial is complete and results will …
Matched conditions: HYPERURICEMIA
Phase: PHASE3 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC